Mimedx (MDXG) EBT Growth (1y) (2012 - 2026)
Mimedx (MDXG) EBT Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | -278.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -278.02% |
| Dec 31, 2025 | 93.75% |
| Sep 30, 2025 | 100.10% |
| Jun 30, 2025 | -43.97% |
| Mar 31, 2025 | -24.52% |
| Dec 31, 2024 | -19.15% |
| Sep 30, 2024 | 21.05% |
| Jun 30, 2024 | 152.98% |
| Mar 31, 2024 | 703.33% |
| Dec 31, 2023 | 41.13% |
| Sep 30, 2023 | 212.66% |
| Jun 30, 2023 | 184.93% |
| Mar 31, 2023 | 81.86% |
| Dec 31, 2022 | 10,732.97% |
| Sep 30, 2022 | -310.84% |
| Jun 30, 2022 | -505.72% |
| Mar 31, 2022 | -25.25% |
| Dec 31, 2021 | 100.52% |
| Sep 30, 2021 | 89.48% |
| Jun 30, 2021 | 78.86% |